| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
PRKCA |
PRKCA, PKCA, PRKACA: Protein kinase C alpha type |
8.867 |
Evidence |
|
| MMP2 |
MMP2, CLG4A: 72 kDa type IV collagenase precursor |
MMP8 |
CLG1, MMP8: Neutrophil collagenase precursor |
8.867 |
Evidence |
|
| C8B |
C8B: Complement component C8 beta chain precursor |
CNTN2 |
CNTN2, AXT, TAG1, TAX1: Contactin-2 precursor |
8.867 |
Evidence |
|
| SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
ANGPTL3 |
ANGPTL3, ANGPT5, UNQ153/PRO179: Angiopoietin-related protein 3 precursor |
8.867 |
Evidence |
|
| TF |
TF, PRO1400: Serotransferrin precursor |
LAMB1 |
LAMB1: Laminin subunit beta-1 precursor |
8.867 |
Evidence |
|
| FGA |
IPI00021885 |
SERPINE1 |
SERPINE1, PAI1, PLANH1: Plasminogen activator inhibitor 1 precursor |
8.867 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
CPB1 |
CPB1, CPB, PCPB: Carboxypeptidase B precursor |
8.867 |
Evidence |
|
| PAK4 |
PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
8.867 |
Evidence |
|
| DAB1 |
DAB1: Disabled homolog 1 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
8.867 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
8.867 |
Evidence |
|
| WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
PIK3R2 |
PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta |
8.867 |
Evidence |
|
| RFX4 |
RFX4: Regulatory factor X4, isoform c |
RFXDC1 |
RFXDC1: Regulatory factor X domain containing 1 |
8.86 |
Evidence |
|
| SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
EIF5AP1 |
EIF5A: Eukaryotic translation initiation factor 5A-1 |
8.845 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
RANGAP1 |
RANGAP1, SD: Ran GTPase-activating protein 1 |
8.845 |
Evidence |
|
| ITGB1BP1 |
ITGB1BP1, ICAP1: Integrin beta-1-binding protein 1 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
8.845 |
Evidence |
|
| CCNB1 |
Cyclin B1 |
CHC1 |
RCC1: RCC1-I (Fragment) |
8.845 |
Evidence |
|
| F2 |
F2: Prothrombin precursor |
MAT1A |
MAT1A, AMS1, MATA1: S-adenosylmethionine synthetase isoform type-1 |
8.827 |
Evidence |
|
| SNAP25 |
SNAP25, SNAP: Synaptosomal-associated protein 25 |
STX12 |
STX12: Syntaxin-12 |
8.82 |
Evidence |
|
| LYN |
LYN: Tyrosine-protein kinase Lyn |
ADAM8 |
ADAM8, MS2: ADAM 8 precursor |
8.817 |
Evidence |
|
| SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
TNPO1 |
|
8.817 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
TNKS2 |
TNKS2, PARP5B, TANK2, TNKL: Tankyrase-2 |
8.817 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
TNKS2 |
TNKS2, PARP5B, TANK2, TNKL: Tankyrase-2 |
8.817 |
Evidence |
|
| WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
LILRB1 |
IPI00385703 |
8.812 |
Evidence |
|
| LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
NCOA3 |
IPI00220082 |
8.812 |
Evidence |
|
| FLT1 |
FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor |
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
8.795 |
Evidence |
|